{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:10:28Z","timestamp":1771409428749,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares, CIBERCV","award":["CB16\/11\/00276"],"award-info":[{"award-number":["CB16\/11\/00276"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Guideline-directed medical therapy (GDMT) remains the cornerstone for treating patients with heart failure (HF) and reduced ejection fraction (HFrEF) and coronary artery disease (CAD). However, real-world implementation of GDMT (GDMTi) is suboptimal. This subanalysis of the RevascHeart study evaluates the impact of GDMTi on long-term mortality in patients with de novo ischaemic heart failure (HF) undergoing revascularization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Among 409 patients with HFrEF (left ventricular ejection fraction \u226440%) and CAD, 275 one-year survivors who underwent revascularisation shortly after index HF admission were included in this landmark analysis (LA). GDMTi at 12 months was defined as initiation of each recommended drug class, regardless of dose. Primary endpoints were all-cause and cardiovascular mortality by GDMTi. Secondary endpoints included outcomes by revascularisation strategy and temporal trends in GDMTi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 41.6 months, all-cause mortality occurred in 29 GDMTi patients (18%) versus 47 non-GDMTi (42%) and cardiovascular mortality in 10% versus 24%, respectively. After adjustment, GDMTi was not significantly associated with lower all-cause [hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.39\u20131.02; P = 0.06] or cardiovascular mortality (HR 0.62, 95% CI 0.33\u20131.18; P = 0.14). GDMTi\/coronary artery bypass grafting (CABG) was associated with lower all-cause (HR 0.42, 95% CI 0.20\u20130.87; P = 0.02) and cardiovascular mortality (HR 0.40, 95% CI 0.16\u20130.99; P = 0.05). GDMTi use increased progressively over the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GDMTi was associated with lower unadjusted mortality, though not significant after adjustment. GDMTi combined with CABG showed the best outcomes. The use of GDMTi improved over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.70014","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T09:49:20Z","timestamp":1763372960000},"page":"4442-4450","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guideline-Directed Medical Therapy After Revascularization and Outcomes in Ischaemic Cardiomyopathy"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-5804","authenticated-orcid":false,"given":"Carlos","family":"Moliner-Ab\u00f3s","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Cardiology Department, Hospital Universitari Dr. Josep Trueta , Girona ,","place":["Spain"]},{"name":"Institut de Recerca Sant Pau (IR SANTPAU) , Barcelona ,","place":["Spain"]},{"name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI) , Girona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Calvo-Barcel\u00f3","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Vall Hebr\u00f3n , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Sol\u00e9-Gonzalez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednic i Provincial de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Borrellas Mart\u00edn","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Germans Tries i Pujol, Badalona, CIBERCV , Badalona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Fluvi\u00e0 Brugu\u00e9s","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Dr. Josep Trueta , Girona ,","place":["Spain"]},{"name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI) , Girona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"S\u00e1nchez Vega","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Vime Jubany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ferr\u00e9 Vallverd\u00fa","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Sant Joan , Reus ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Taur\u00f3n Ferrer","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institut de Recerca Sant Pau (IR SANTPAU) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Eduardo","family":"Tobias Castillo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Vall Hebr\u00f3n , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"de la Fuente Mancera","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednic i Provincial de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Vilardell Rigau","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Dr. Josep Trueta , Girona ,","place":["Spain"]},{"name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI) , Girona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Vila Olives","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Vall Hebr\u00f3n , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Diez L\u00f3pez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Bay\u00e9s-Gen\u00eds","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Germans Tries i Pujol, Badalona, CIBERCV , Badalona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dabit","family":"Arzamendi Aizpurua","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institut de Recerca Sant Pau (IR SANTPAU) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ferreira Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitari Vall Hebr\u00f3n , Barcelona ,","place":["Spain"]},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f2nia","family":"Mirabet P\u00e9rez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu i Sant Pau, CIBERCV, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institut de Recerca Sant Pau (IR SANTPAU) , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2026021804184575300_ehf270014-bib-0001","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2026021804184575300_ehf270014-bib-0002","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0002-8703(89)90685-6","article-title":"The hibernating myocardium","volume":"117","author":"Rahimtoola","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2026021804184575300_ehf270014-bib-0003","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/nejmoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2026021804184575300_ehf270014-bib-0004","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/nejmoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2026021804184575300_ehf270014-bib-0005","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.3463","article-title":"Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: the RevascHeart study","volume":"27","author":"Moliner-Ab\u00f3s","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026021804184575300_ehf270014-bib-0006","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/ejhf.3445","article-title":"Heart failure in Europe: guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction\u2014the ESC EORP Heart Failure III Registry","volume":"26","author":"Lund","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804184575300_ehf270014-bib-0007","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cardfail.2023.01.005","article-title":"Time to triple therapy in patients with de novo heart failure with reduced ejection fraction: a population-based study: time to triple therapy in heart failure","volume":"29","author":"Sepehrvand","year":"2023","journal-title":"J Card Fail"},{"key":"2026021804184575300_ehf270014-bib-0008","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026021804184575300_ehf270014-bib-0009","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00392-023-02241-0","article-title":"Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction","volume":"113","author":"Esteban-Fern\u00e1ndez","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026021804184575300_ehf270014-bib-0010","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026021804184575300_ehf270014-bib-0011","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804184575300_ehf270014-bib-0012","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026021804184575300_ehf270014-bib-0013","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00392-024-02498-z","article-title":"Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013\u20132020","volume":"113","author":"Karlstr\u00f6m","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026021804184575300_ehf270014-bib-0014","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","journal-title":"Lancet"},{"key":"2026021804184575300_ehf270014-bib-0015","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (surgical treatment for ischemic heart failure): mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026021804184575300_ehf270014-bib-0016","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.jtcvs.2020.12.094","article-title":"Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy","volume":"164","author":"Farsky","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026021804184575300_ehf270014-bib-0017","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/eurheartj\/ehaf080","article-title":"Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis","volume":"46","author":"Ryan","year":"2025","journal-title":"Eur Heart J"},{"key":"2026021804184575300_ehf270014-bib-0018","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026021804184575300_ehf270014-bib-0019","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"2026021804184575300_ehf270014-bib-0020","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/nejmoa1812851","article-title":"Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/4442\/66968434\/eschf_12_6_4442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/4442\/66968434\/eschf_12_6_4442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:18:56Z","timestamp":1771406336000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/6\/4442\/8488188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,17]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.70014","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"2025-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}